A double-blind cross-over trial of fenoprofen and phenylbutazone in ankylosing spondylitis.

Fenoprofen, 600 mg, three times daily, was compared with phenylbutazone, 100 mg, three times daily, in 30 patients suffering from ankylosing spondylitis in a double-blind cross-over study. Assessments were made after an initial washout period and after each month-long treatment period. Phenylbutazon...

Cijeli opis

Bibliografski detalji
Glavni autori: Wordsworth, B, Ebringer, R, Coggins, E, Smith, S
Format: Journal article
Jezik:English
Izdano: 1980